Gene · 3549
Papers2,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential of Using Infrapatellar-Fat-Pad-Derived Mesenchymal Stem Cells for Therapy in Degenerative Arthritis: Chondrogenesis, Exosomes, and Transcription Regulation. | Biomolecules | 2022 | 35327578 | PubTator, text mining | PubMed |
| Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? | Cells | 2022 | 35326398 | PubTator, text mining | PubMed |
| Gastric epithelial histology and precancerous conditions. | World J Gastrointest Oncol | 2022 | 35317321 | PubTator, text mining | PubMed |
| Altered Expression of the Hedgehog Pathway Proteins BMP2, BMP4, SHH, and IHH Involved in Knee Cartilage Damage of Patients With Osteoarthritis and Kashin-Beck Disease. | Cartilage | 2022 | 35313742 | PubTator, text mining | PubMed |
| GSK-3β suppression upregulates Gli1 to alleviate osteogenesis inhibition in titanium nanoparticle-induced osteolysis. | J Nanobiotechnology | 2022 | 35305665 | PubTator, text mining | PubMed |
| Primary cilia on muscle stem cells are critical to maintain regenerative capacity and are lost during aging. | Nat Commun | 2022 | 35301320 | PubTator, text mining | PubMed |
| Serum Glucose Measurement after Five to Six Hours is Comparable to Eight Hours Fasting in Ramadan. | Sultan Qaboos Univ Med J | 2022 | 35299797 | PubTator, text mining | PubMed |
| Bone morphogenetic protein receptor 1α promotes osteolytic lesion of oral squamous cell carcinoma by SHH-dependent osteoclastogenesis. | Cancer Sci | 2022 | 35279920 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapy for myocardial infarction. | Signal Transduct Target Ther | 2022 | 35273164 | PubTator, text mining | PubMed |
| Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes. | Front Pharmacol | 2022 | 35264950 | PubTator, text mining | PubMed |
| Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage. | Drug Deliv | 2022 | 35261301 | PubTator, text mining | PubMed |
| SOX4 facilitates PGR protein stability and FOXO1 expression conducive for human endometrial decidualization. | Elife | 2022 | 35244538 | PubTator, text mining | PubMed |
| Tumor microenvironment pathways: Cross regulation in breast cancer metastasis. | Genes Dis | 2022 | 35224148 | PubTator, text mining | PubMed |
| Identification, Culture and Targeting of Cancer Stem Cells. | Life (Basel) | 2022 | 35207472 | PubTator, text mining | PubMed |
| Chloride Channels and Transporters: Roles beyond Classical Cellular Homeostatic pH or Ion Balance in Cancers. | Cancers (Basel) | 2022 | 35205604 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment. | Theranostics | 2022 | 35198064 | PubTator, text mining | PubMed |
| Pathogenic and Potential Therapeutic Roles of Exosomes Derived From Immune Cells in Liver Diseases. | Front Immunol | 2022 | 35185900 | PubTator, text mining | PubMed |
| O-fucosylation of thrombospondin type 1 repeats is essential for ECM remodeling and signaling during bone development. | Matrix Biol | 2022 | 35167946 | PubTator, text mining | PubMed |
| On the horizon: Hedgehog signaling to heal broken bones. | Bone Res | 2022 | 35165260 | PubTator, text mining | PubMed |
| Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance. | Int J Mol Sci | 2022 | 35163655 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3549/papers?page=30